OSSTEC
3D printed bone-like titanium implants for joint replacement enabling faster recovery
- CEO / Founder
- Dr. Maxwell Munford
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $4.7M
- Latest Round
- Series A
- Key Investors
- Empirical Ventures, SFC Capital, Oxford Innovation Finance, Parkwalk Advisors, Embryo Ventures, Imperial College Enterprise Fund
Technology & Products
Key Products
ASCENT™ 3D printed unicondylar (partial) knee with biomimetic cementless fixation; CLARITY™ instrumentation
Technological Advantage
Patented 3D printing technology from 10 years Imperial College research mimicking cartilage and bone structures
Differentiation
Value Proposition
Cementless 3D printed lattice implants enabling same-day discharge without bone cement complications
How They Differentiate
Bone-like lattice structure vs solid metal implants, enabling cementless fixation
Market & Competition
Target Customers
Orthopedic surgeons, hospitals, outpatient surgery centers
Industry Verticals
Orthopedics, Medical Devices, Joint Replacement, Healthcare
Competitors
Stryker, Zimmer Biomet, Smith & Nephew
Growth & Milestones
Growth Metrics
CEO nominated for Entrepreneur of the Year
Major Milestones
Spinout from Imperial College PhD (2021), £1.2M Seed (2023), £2.5M Series A led by Empirical Ventures (2025)
Notable Customers
UK healthcare system (targeted)
AM patents
AM-relevant patents linked to this company.
- Patents
- 2
- Granted
- 0
- Families
- 2
Leading domains: application (2), process (2)
Filings by year: 2023: 2
- TIBIAL COMPONENT2025068688 · WO
- IMPLANT COMPONENT2025068687 · WO
Funding rounds
- Series A£2.5M2025-04Lead: Empirical Ventures · Source: Press
- Seed£1.2M2023-03Source: Press